Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis
Sanghamitra Mohanty(Texas Cardiac Arrhythmia), Andrea Natale(St David's Medical Center), Carola Gianni(St David's Medical Center), G. Joseph Gallinghouse(St David's Medical Center), Rodney Horton(St David's Medical Center), John D. Allison(St David's Medical Center), Amin Al‐Ahmad(St David's Medical Center), Mohamed Bassiouny(St David's Medical Center), Vincenzo Mirco La Fazia(University of Rome Tor Vergata), Merve Kurt(Mount Auburn Hospital), Angel Mayedo(St David's Medical Center), Prem Geeta Torlapati(St David's Medical Center), Bryan MacDonald(St David's Medical Center), John Burkhardt(St David's Medical Center), Luigi Di Biase(Albert Einstein College of Medicine)
Cited by 21
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
|Circulation|2016|855
Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?
|Journal of the American College of Cardiology|2012|834
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763